Introducing the pneumococcal conjugate vaccine in India's National Immunization Programme: an economic-epidemiological analysis using agent-based modelling

Research output: Contribution to conferenceAbstractpeer-review


Pneumococcal pneumonia causes over 100,000 child deaths in India annually. Uncertainty regarding the impact of introducing the pneumococcal conjugate vaccine and its high cost have been a concern, particularly after the proposed GAVI alliance support ends. We evaluate disease transmission and the vaccine’s disease and economic impact in an agent-based simulation model representative of the Indian population and healthcare system. Despite its high cost, introducing the vaccine averts a significant number of deaths and protects poor populations from financial risk.
Original languageEnglish
Number of pages1
Publication statusPublished - 28 Jul 2017
EventINFORMS Healthcare 2017 - Rotterdam, Netherlands
Duration: 26 Jul 201728 Jul 2017


ConferenceINFORMS Healthcare 2017
Internet address


  • india
  • national immunization programme

Cite this